PCN99 Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan

Kostyuk, A.Nurgozhin, T.Mazhitov, T.Almadiyeva, A.2017-12-142017-12-142014-05-01A. Kostyuk, T. Nurgozhin, T. Mazhitov, A. Almadiyeva, PCN99 - Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in Kazakhstan, In Value in Health, Volume 17, Issue 3, 2014, Page A8510983015https://www.sciencedirect.com/science/article/pii/S1098301514005452http://nur.nu.edu.kz/handle/123456789/2888PCN99 Cost-Effectiveness Evaluation of Sunitinib as First-Line Targeted Therapy for Metastatic Renal Cell Carcinoma in KazakhstanArticleCopyright © 2014 Published by Elsevier Inc.